<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: StrataGent closes $16M round for needle-free injections</title>
	<atom:link href="http://venturebeat.com/2007/05/11/stratagent-closes-16m-round-for-needle-free-injections/feed/" rel="self" type="application/rss+xml" />
	<link>http://venturebeat.com/2007/05/11/stratagent-closes-16m-round-for-needle-free-injections/</link>
	<description>News About Tech, Money and Innovation</description>
	<lastBuildDate>Mon, 23 Nov 2009 03:59:39 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.5</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: VentureBeat &#187; Life sciences briefing: Thursday, Sept. 27, 2007</title>
		<link>http://venturebeat.com/2007/05/11/stratagent-closes-16m-round-for-needle-free-injections/comment-page-1/#comment-554710</link>
		<dc:creator>VentureBeat &#187; Life sciences briefing: Thursday, Sept. 27, 2007</dc:creator>
		<pubDate>Thu, 27 Sep 2007 14:32:15 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2007/05/11/stratagent-closes-16m-round-for-needle-free-injections/#comment-554710</guid>
		<description>[...] in a microprocessor-controlled device resembling an electronic patch. (See our previous coverage here.) The company raised a $16 million round in May, although the company never received more than $6.7 [...]</description>
		<content:encoded><![CDATA[<p>[...] in a microprocessor-controlled device resembling an electronic patch. (See our previous coverage here.) The company raised a $16 million round in May, although the company never received more than $6.7 [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: VentureBeat &#187; Life sciences briefing: Monday, Aug. 13, 2007</title>
		<link>http://venturebeat.com/2007/05/11/stratagent-closes-16m-round-for-needle-free-injections/comment-page-1/#comment-423040</link>
		<dc:creator>VentureBeat &#187; Life sciences briefing: Monday, Aug. 13, 2007</dc:creator>
		<pubDate>Mon, 13 Aug 2007 21:49:27 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2007/05/11/stratagent-closes-16m-round-for-needle-free-injections/#comment-423040</guid>
		<description>[...] injection system. We&#8217;ve written about other startups pursuing similar technology, including StrataGent Life Sciences and [...]</description>
		<content:encoded><![CDATA[<p>[...] injection system. We&#8217;ve written about other startups pursuing similar technology, including StrataGent Life Sciences and [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: VentureBeat &#187; Brownian motion: Personnel moves within the life sciences</title>
		<link>http://venturebeat.com/2007/05/11/stratagent-closes-16m-round-for-needle-free-injections/comment-page-1/#comment-401560</link>
		<dc:creator>VentureBeat &#187; Brownian motion: Personnel moves within the life sciences</dc:creator>
		<pubDate>Fri, 10 Aug 2007 23:37:01 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2007/05/11/stratagent-closes-16m-round-for-needle-free-injections/#comment-401560</guid>
		<description>[...] of complex drugs, similar in certain ways to StrataGent Life Sciences, which we wrote about here. Here is the company&#8217;s [...]</description>
		<content:encoded><![CDATA[<p>[...] of complex drugs, similar in certain ways to StrataGent Life Sciences, which we wrote about here. Here is the company&#8217;s [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Mark Wendman</title>
		<link>http://venturebeat.com/2007/05/11/stratagent-closes-16m-round-for-needle-free-injections/comment-page-1/#comment-144831</link>
		<dc:creator>Mark Wendman</dc:creator>
		<pubDate>Mon, 14 May 2007 21:01:13 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2007/05/11/stratagent-closes-16m-round-for-needle-free-injections/#comment-144831</guid>
		<description>This website from a UCSB professor affiliated with the firm, has a boatload of !! 28 patents for mostly ultrasound transdermal drug delivery.

Looks like the main source of the firm&#039;s core technology to me, unless there are more than  these patents owned or licensed by the firm...

http://drugdelivery.engr.ucsb.edu/Patents.htm

Prof. Samir Mitragotri http://drugdelivery.engr.ucsb.edu/  in UCSB&#039;s Dept. of Chemical Engineering, is shown to be affiliated with the technical effort by this UCSB press release.

http://www.engineering.ucsb.edu/news/132
as Dave linked to above..</description>
		<content:encoded><![CDATA[<p>This website from a UCSB professor affiliated with the firm, has a boatload of !! 28 patents for mostly ultrasound transdermal drug delivery.</p>
<p>Looks like the main source of the firm&#8217;s core technology to me, unless there are more than  these patents owned or licensed by the firm&#8230;</p>
<p><a href="http://drugdelivery.engr.ucsb.edu/Patents.htm" rel="nofollow">http://drugdelivery.engr.ucsb.edu/Patents.htm</a></p>
<p>Prof. Samir Mitragotri <a href="http://drugdelivery.engr.ucsb.edu/" rel="nofollow">http://drugdelivery.engr.ucsb.edu/</a>  in UCSB&#8217;s Dept. of Chemical Engineering, is shown to be affiliated with the technical effort by this UCSB press release.</p>
<p><a href="http://www.engineering.ucsb.edu/news/132" rel="nofollow">http://www.engineering.ucsb.edu/news/132</a><br />
as Dave linked to above..</p>
]]></content:encoded>
	</item>
</channel>
</rss>
